Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Advanced Retina Institute provides state-of-the-art retinal care and participates in clinical trials for new treatments. Dr. Tsipursky, the founder, has served as principal investigator on multiple retinal disease studies and holds several patents. He is also CEO/co-founder of ReVive Biotechnology, which develops therapeutics for blinding retinal conditions with support from NSF grants and private investment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Advanced Retina.